Kussmann J, Hirche H, Sengupta R
Dtsch Med Wochenschr. 1983 Mar 25;108(12):449-52. doi: 10.1055/s-2008-1069575.
Antithrombin III activity was estimated using a chromogenic substrate perioperatively in the plasma of 200 patients undergoing major elective abdominal surgery during low-dose heparin prophylaxis. With an initial value of 10.9 +/- 2 IU/ml there was a mean postoperative lowering of plasma antithrombin activity in all patients with a minimum on the second postoperative day. In patients with empirically established increased risk of thromboembolism the postoperative depression of antithrombin was significantly more pronounced (P less than 0.01) than in the control groups. An increased risk prevailed particularly in patients with malignant diseases and in major surgery, i.e. of prolonged duration. In such cases with increased risk of thromboembolism routine assessment of antithrombin III is recommended.
在200例接受大剂量择期腹部手术的患者中,在低剂量肝素预防期间,使用发色底物在围手术期测定血浆抗凝血酶III活性。初始值为10.9±2 IU/ml,所有患者术后血浆抗凝血酶活性均有平均降低,术后第二天降至最低。在经验性确定血栓栓塞风险增加的患者中,抗凝血酶的术后降低比对照组明显更显著(P<0.01)。血栓栓塞风险增加尤其在患有恶性疾病和进行大手术(即手术时间延长)的患者中更为常见。在这种血栓栓塞风险增加的情况下,建议常规评估抗凝血酶III。